Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Survey: China Sees Rapid Resistance To HIV Drugs

This article was originally published in PharmAsia News

Executive Summary

A national survey of China reveals that in excess of 17 percent of its HIV patients developed drug resistance to the seven drugs available in the country. Government researchers revealed the survey results at an international AIDS conference. They noted that only seven of more than 20 HIV drugs are available in China, allowing resistance to be built up more quickly than in countries where patients have more drug options. The instances of resistance occurred during 2006 and 2007 even though China began its free-drug program in 2003, indicating a more rapid mutation of the virus than usually expected. The researchers also said resistance appeared more prevalent among families with low and unstable incomes. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel